New – cannabis.co.nz

January 11, 20232022, 2023, Act, agencies, analysis, analytics, banking, Biden, Brownstein, Brownstein Hyatt Farber Schreck, business, Business Analysis, california, cannabis, Cannabis Opportunity Act, CAOA, cbd, challenge, CLIMB, compliance, consumer, controlled substances act, CSA, cultivation, department of justice, dispensary, DOJ, extraction, Federal, government, growing, Harnessing Opportunities by Pursuing Expungement, HOPE, industry, Joe, law, legal, legalization, legalize, legislation, license, LLP, marijuana, Marijuana Opportunity Reinvestment and Expungement, market, medical, medicine, MORE, New, pardon, president, product, Quality, recreational, regulation, regulations, regulatory, safe, safety, state, thc, the States Reform Act, year

Cannabis in 2023: Here to Stay, but Major Challenges Remain

2022 brought more change and visibility to the cannabis industry than nearly any year before. Two of five legalization ballot measures passed, […]

July 7, 2022additive, analysis, analytics, business, Business Analysis, cannabidiol, cannabis, cbd, compliance, consumer, data, derived, dietary, drug, Edibles & Processing, EFSA, EU, europe, extraction, FDA, Federal, food, Gendel Food Safety, government, gras, growing, hemp, industry, international, lab, laboratories, laboratory, labs, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, New, novel, product, Product Development, Quality, recreational, regulation, regulations, regulatory, retail, review, safety, state, Steven Gendel, test, Testing, thc, US

CBD Safety in Edibles: What Regulators are Thinking

Despite the popularity of cannabidiol (CBD) infused edibles among consumers there are storm clouds on the horizon for this market. The potential […]

April 20, 2022action, analysis, analytics, approval, approved, business, Business Analysis, cannabidiol, cannabis, cbd, claim, compliance, Concentrates & Extracts, consumer, Coronavirus, COVID, COVID-19, cultivation, drug, Edibles & Processing, enforcement, extraction, farm bill, FD&C act, FDA, Federal, government, growing, Health, industry, lab, law, legal, legalization, legalize, legislation, letter, license, marijuana, market, medical, medicine, New, product, Product Development, Quality, regulation, regulations, regulatory, research, retail, safety, state, test, Testing, thc, threaten, U.S. Food and Drug Administration, unapproved, unsubstantiated, warning, wellness

FDA Warning Letters: Stop Claiming CBD Prevents COVID

Once again, the U.S. Food and Drug Administration (FDA) has issued a number of warning letters to companies selling hemp-derived cannabidiol (CBD) […]

January 29, 2022analysis, analytics, Benjamin, business, cannabis, Cannabis Regulatory Commission, compliance, consumer, CRC, deadline, government, growing, industry, Jeff Brown, Jersey, law, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, New, NJ, product, recreational, regulation, regulations, regulatory, retail, sales, state

New Jersey Adult Use Program Likely Delayed

Back in November of 2020, voters in New Jersey overwhelmingly approved Question 1, the ballot measure to legalize cannabis. On February 22, […]

September 2, 2021analysis, analytics, business, Business Analysis, cannabis, compliance, compliant, consistent, contaminate, contamination, control, cultivation, Cultivation & Growing, document, documentation, Edibles & Processing, electronic, employ, employee, extraction, government, growing, hire, hiring, industry, law, leadership, legal, legalization, legalize, legislation, license, manage, marijuana, market, New, Operations, policies, policy, process, processing, product, Quality, regulation, regulatory, safety, sop, staff, stakeholder, standard operating procedure, standardized, state, teach, teaching, team, test, train, training, turnover, written

Best Practices for Training New Hires and Documenting Operations

Let’s just say it. There is an undeniable chaos in the cannabis industry. It doesn’t matter if you’re a big or small […]

November 3, 202019, 2020, 2021, 280E, acquisition, analysis, analytics, annual, appellations, beverages, business, Business Analysis, CA, calcannabis, Cali, california, cannabinoid, cannabis, cbd, competition, compliance, consolidation, consumer, Coronavirus, COVID, COVID-19, cultivate, cultivating, cultivation, Cultivation & Growing, Dispensaries & Retail, dispensary, distribution, distributor, equity, Federal, finance, financial, forecast, formalize, government, growing, hemp, industry, jurisdiction, lab, law, legal, legalization, legalize, legislation, license, Licesning, liquidity, marginalized, marijuana, market, medical, medicine, merger, New, niche, opportunities, pandemic, price, product, Product Development, products, project, Quality, quarantine, recreational, regulation, regulatory, restrictions, retail, services, social, spending, state, Sustainability, tax, thc, turmoil, year

2021 Trends: Nine Developments in California’s Cannabis Market

While we’re pleased to report that 2020 is almost over, 2021 will be a mixed bag. New jurisdictions will open their doors […]

October 28, 20201, analysis, analytics, and Cosmetics Act, application, approval, approve, business, Business Analysis, cannabidiol, cannabis, cbd, clinical, clinical trials, compliance, consumer packaged goods, CPG, CSA, dea, derived, deschedule, descheduled, Dravet syndrome, drug, Drug Enforcement Administration, Epidiolex, epilepsy, extraction, FDA, FDCA, Federal, Federal Food, FFDCA, food and drug administration, formulation, government, GW, GW Pharma, hemp, industry, law, legal, legalization, legalize, legislation, Lennox-Gastaut syndrome, license, marijuana, market, medical, medicine, New, patent, pathway, patient, pharma, pharmaceutical, product, Product Development, program, regulation, regulations, regulatory, REMS, safety, schedule, seizures, state, Substances, thc, trial, TSC

How GW Pharma Won CBD

As of this writing, the United States Food and Drug Administration (FDA) has approved GW Pharma’s CBD drug Epidiolex for treating profound […]

August 19, 2020analysis, analytics, anxiety, Arizona, business, Business Analysis, california, cannabis, cbd, change, colorado, compliance, consumer, Coronavirus, COVID, COVID-19, cultivation, Dispensaries & Retail, dispensary, employee, employer, essential, extraction, Federal, glove, government, growing, hemp, hire, hiring, industry, law, learning, legal, legalization, legalize, legislation, license, marijuana, market, medical, medicine, New, norm, normal, Operations, pandemic, paycheck, personnel, pivot, PPE, PPP, product, Product Development, program, protection, protocol, Quality, recreational, regulation, regulatory, remote, retail, safety, SBA, small business administration, staffing, state, tele, telehealth, test, Testing, thc

Cannabis & COVID: Changes, Advances & Opportunities

The onset of the COVID-19 pandemic sent shockwaves around the world, and they’re still rippling today. Businesses had to quickly pivot from […]